Atlas FDA

HEMOCUE AB GLUCOSE 201 DM ANALYZER, in vitro diagnostic device for quantitative determination of blood glucose level.

FDA device recall Z-1848-2011 · posted 2011-03-30 · Terminated

Recall details

Recalling firm
Hemo Cue, Inc.
Reason for recall
Incorrect configurations settings in software. As a result, certain error codes do not trigger appropriately. These error codes are: E01, E02 and E05 which are all related to the optronic performance of the analyzer. Possible incorrect results.
Action taken
Hemocue AB sent Customer Notification "Notice of Medical Device Correction on HemoCue Glucose 201 DM and HemoCue Hb 201 DM Analyzers" dated October 7, 2010, to customers notifying them of incorrect settings on error codes. The corrective action consists of an update of the configuration settings on the the affected HemoCue Glucose 201 DM and Hb 201 DM analyzers that are in the field. The affected units in the field will be corrected in accordance with a rework procedure that has been established by HemoCue AB.
Root cause
Process control
Status
Terminated
Product code
CGA
Quantity affected
23
Distribution
Worldwide distribution, including USA, and Glucose 201 DM analyzers to Norway and the Netherlands; Hb 201 DM analzyers to the Netherlands, France, Ireland, Great Britain, Poland and Germany.
Date initiated
2010-10-07
Date posted
2011-03-30
Date terminated
2011-06-22
Location
Cypress, CA

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
CLINICAL LABORATORY ANALYZING SYSTEM (K041230)Hemocue, Inc.2004-05-20